Globe Life Inc

Globe Life Inc (GL) Stock Analysis

$172.790

-2.937 (-1.70%)At close

Loading chart…
High
177.000
Open
176.530
VWAP
174.16
Vol
454.86K
Mkt Cap
7.59B
Low
172.700
Amount
79.22M
EV/EBITDA, TTM
9.64

Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company's segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.

AI analysis of Globe Life Inc (GL)

hold

Globe Life Inc is currently priced at $172.79, which is below the average analyst price target of $201. However, the stock's RSI is at 38.665, indicating it is nearing oversold territory, which could present a buying opportunity. The recent insider selling has increased by 1066.49%, which raises concerns about confidence in the stock's future performance. Given these factors, it may be prudent to hold off on buying until there is clearer upward momentum or a reversal in insider activity.

Valuation Metrics

The current forward P/E ratio for Globe Life Inc (GL) is 11.19, compared to its 5-year average forward P/E of 10.17.

Forward P/E

Fair
5Y Average P/E
10.17
Current P/E
11.19
Overvalued
11.77
Undervalued
8.57

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.05
Current EV/EBITDA
9.64
Overvalued
10.29
Undervalued
7.81

Forward P/S

Fair
5Y Average P/S
1.78
Current P/S
1.98
Overvalued
1.99
Undervalued
1.57

Alphio AI Price Scenarios for GL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%GL

$153.34

Scenario price

B

Base

Base · 50%GL

$130.63

Scenario price

B

Bear

Bear · 25%GL

$130.62

Scenario price

Whales holding GL

I

Ingalls & Snyder, LLC

+ HoldingGL

+19.41%

3M Return

E

Equity Investment Corporation

+ HoldingGLPNC

+10.66%

3M Return

R

Regions Investment Management, Inc.

+ HoldingGL

+3.73%

3M Return

A

Arbejdsmarkedets Tillægspension (Atp)

+ HoldingGL

+2.17%

3M Return

I

Interval Partners, LP

+ HoldingGL

-2.40%

3M Return

GL FAQ — answered by Alphio AI

Globe Life Inc. is an insurance holding company. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company's segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The Company offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare. It operates in the Financials sector (LIFE INSURANCE industry).

Globe Life Inc is currently priced at $172.79, which is below the average analyst price target of $201. However, the stock's RSI is at 38.665, indicating it is nearing oversold territory, which could present a buying opportunity. The recent insider selling has increased by 1066.49%, which raises concerns about confidence in the stock's future performance. Given these factors, it may be prudent to hold off on buying until there is clearer upward momentum or a reversal in insider activity.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started